首页> 外文期刊>Life sciences >Chlorinated dibenzo-p-dioxins and dibenzofurans and the human immune system. 2. In vitro proliferation of lymphocytes from workers with quantified moderately-increased body burdens.
【24h】

Chlorinated dibenzo-p-dioxins and dibenzofurans and the human immune system. 2. In vitro proliferation of lymphocytes from workers with quantified moderately-increased body burdens.

机译:氯化二苯并-对-二恶英和二苯并呋喃与人类免疫系统。 2.定量减轻了身体负担的工人的淋巴细胞体外增殖。

获取原文
获取原文并翻译 | 示例
           

摘要

Lymphocyte proliferation responses were studied in workers with moderately increased body burdens of 2,3,7,8-tetrachlorodibenzo-p-dioxin and other polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDDs/PCDFs, calculated as International Toxicity Equivalencies [I-TE]). Mitogens (pokeweed mitogen [PWM], phytohemagglutinine [PHA], concanavalin A [Con A]), as well as an anti-human monoclonal antibody against CD3 were used as proliferation stimulators in vitro. Additionally, the feasibility of using the lymphocyte response to tetanus toxoid was assessed, and the response to this recall-antigen was included in this trial. No decrease in the capacity of 3H-thymidine incorporation was observed with any of the proliferation stimulators in the group of volunteers with the increased TCDD-body burden when compared with volunteers exhibiting TCDD-concentrations in blood fat within the reference range. Regression analysis revealed a slight trend towards an increase for 3H-thymidine incorporation during the stimulation with PHA only. It can be concluded from our data that moderate increases in the TCDD- or I-TE-body burdens do not induce any medically significant changes in the capacity for proliferation of lymphocytes, measured as 3H-thymidine incorporation.
机译:研究人员在身体负担适度增加的2,3,7,8-四氯二苯并-对-二恶英和其他多氯代二苯并-对二恶英和二苯并呋喃(PCDDs / PCDFs,按国际毒性当量[I-TE ])。有丝分裂原(商陆有丝分裂原[PWM],植物血凝素[PHA],伴刀豆球蛋白A [Con A])以及抗CD3的抗人单克隆抗体被用作体外的增殖刺激物。此外,评估了使用对破伤风类毒素的淋巴细胞反应的可行性,并且在该试验中包括了对这种召回抗原的反应。与在参考范围内血脂中TCDD浓度较高的志愿者相比,在具有TCDD身体负担增加的志愿者组中,未发现任何增殖刺激剂的3H-胸腺嘧啶核苷掺入能力降低。回归分析显示在仅用PHA刺激期间3H-胸苷掺入量有轻微增加趋势。从我们的数据可以得出结论,以3H-胸腺嘧啶核苷的掺入量计,TCDD或I-TE体负荷的适度增加不会引起淋巴细胞增殖能力的任何医学显着变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号